Lv0
0 积分 2025-07-08 加入
Antibody–drug conjugates come of age in oncology
18天前
已完结
Antibody–drug conjugates for non-muscle invasive bladder cancer: current status and future development
19天前
已完结
Comparison of [68Ga]Ga-HER2 Affibody PET/CT and MRI for the early prediction of response to targeted neoadjuvant therapy in breast cancer
29天前
已完结
Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring
29天前
已完结
HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer
29天前
已完结
HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer
30天前
已完结
Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings
30天前
已完结
Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: strategies for prevention and treatment
2个月前
已关闭
The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
4个月前
已完结
RC48-Antibody-Drug Conjugate in Metastatic Urothelial Carcinoma: A Multicenter Real-World Study in China
4个月前
已完结
皖公网安备34019202002308
